Showing results (31-40 of 896) with videos related to
Sort By:
Pageof 90
Current Opinion in Biotechnology|December 3, 2002
Production of clinical-grade recombinant adeno-associated virus vectorsRichard O Snyder, Terence R FlotteFASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 9, 2019
The rapidly evolving state of gene therapyAlisha M Gruntman, Terence R FlotteAnnual Review of Virology|July 9, 2019
Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?Allison M Keeler, Terence R FlotteCytokine|September 10, 2008
CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetesMichael S Stalvey, Todd M Brusko, Christian Mueller, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 1, 2025
Gene therapy then and now: A look back at changes in the field over the past 25 yearsDan Wang, Gregg Stevens, Terence R FlotteInternational Journal of Molecular Sciences|April 14, 2026
Immune Toxicities in AAV Gene Therapy: Overview for CliniciansShestruma Parajuli, Thomas Gallagher, Terence R FlotteClinical Pharmacokinetics|September 12, 2002
Virus-based gene delivery systemsCathryn Mah, Barry J Byrne, Terence R FlotteMethods in Molecular Biology (Clifton, N.J.)|December 18, 2023
Alpha-1 Antitrypsin DeficiencyAlisha M Gruntman, Wen Xue, Terence R FlotteMethods in Molecular Biology (Clifton, N.J.)|July 29, 2017
Quantification of Total Human Alpha-1 Antitrypsin by Sandwich ELISAQiushi Tang, Alisha M Gruntman, Terence R FlotteHuman Gene Therapy|March 22, 2021
CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene EditingIshani Dasgupta, Terence R Flotte, Allison M KeelerPageof 90